Home » Abbott, Medtronic Stent Sales May Rise on Study
Abbott, Medtronic Stent Sales May Rise on Study
Abbott Laboratories and Medtronic Inc. are poised to seize a third of the $5 billion in annual heart-stent sales with new versions of the drug-coated devices.
The Boston Globe
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May